2024 annual financial data
Relmada Therapeutics 2024 Operating margin
Relmada Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -83,891,036 USD and net income was -79,979,354 USD.
Operating cash flow was -51,755,798 USD.
Get free Relmada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -83,891,036 USD
- Net income
- -79,979,354 USD
- Operating cash flow
- -51,755,798 USD